PharmaSpotter
SearchVendors
HomeSearchEnnov Pharmacovigilance Suite (PV-Works)
Ennov logo

Ennov Pharmacovigilance Suite (PV-Works)

by Ennov
Visit Product Website
PharmacovigilancePharmacovigilancePharma Edition Available

Cloud or on-premises ICSR/safety database for collecting, processing and reporting human and veterinary adverse events to global regulators, targeted at mid-sized pharma, CROs, generics manufacturers and animal-health companies, differentiated by configurable workflows usable without IT staff and dual human/veterinary coverage on one platform.

Ennov's pharmacovigilance product line comprises modules — "Ennov Doc for PV," "Case Intake & Management," "Reporting & Data Analysis," "Signal Detection & Management" — on top of the safety database marketed as "Ennov PV-Works" (with separate "PV-Works Human" and "PV-Works Vet" editions). The Vet edition supports EUVeterinary XML and FDA CVM HL7 formats.

Ennov entered the PV market by acquiring UK-based Assured Information Systems in July 2014. PV-Works subsequently became the Ennov pharmacovigilance solution. Document archives under pv247.com / pv247.ennov.com retain the AIS letterhead.

Functionally the suite covers ICSR intake (manual entry, E2B import, PDF/web case-capture forms with auto-translation), MedDRA-coded case processing, workflow routing, electronic submission to EMA and FDA via AS2 gateway, aggregate reports (PSUR, DSUR, PBRER, PADER, CIOMS, MedWatch 3500), and an integrated signal-detection module (PV-Analyzer / Signal Detection & Management) calculating PRR, ROR and MGPS disproportionality measures.

Pharmaceutical Edition

Two pharma-specific editions: PV-Works Human (human drug ICSRs) and PV-Works Vet (veterinary ICSRs supporting EUVeterinary XML and FDA CVM HL7 formats).

Key Features & Capabilities

Core Capabilities

Case intake (multi-channel): manual entry via web forms; PDF intake forms; mobile-optimised browser web forms; E2B import; local-language capture with automatic translation at import
AI-powered triage and extraction (Version 11.0 released Dec 2025 adds platform-wide AI capabilities)
ICSR processing & workflow via configurable BPM workflow engine (Ennov Process); colour-coded timeliness indicators; reassignment and workload supervision
MedDRA coding: built-in dictionary, updated each release; VeDDRA supported for veterinary cases
E2B(R2) and E2B(R3) import/export including FDA ISO-8859-1 variant and EVCTM for clinical-trial cases
Electronic submission via AS2 gateway with acknowledgment matching; aggregate reporting (PSUR, DSUR, PBRER, CIOMS, MedWatch 3500)
Signal detection (PV-Analyzer): PRR, ROR, MGPS Bayesian disproportionality; stratification; signal repository workflow; can deploy standalone using E2B feeds
PSMF and PV-document management via Ennov Doc for PV — GVP Module II structured binder with Part 11 controls
Regulatory Compliance

FDA & GxP Compliance

FDA 21 CFR Part 11
GxP Compliant

Security Certifications

ISO 27001

Data Integrity & Validation

Electronic Signatures
Validation Documentation
Technical Specifications

Deployment: single-tenant private cloud (Microsoft Azure or OVHcloud) or on-premises. Vendor states customers can switch between deployment options. No claim of multi-tenant SaaS architecture. "Data can be hosted locally for total flexibility". Specific Azure/OVH region list not published.

Access: 100% web-based, modern browser; mobile-optimised intake forms for smartphone/tablet; lightweight PDF intake form alternative. Native mobile applications not advertised. SSO: login realm uses Keycloak (login.ennov.com/realms/EnnovSupport), which supports SAML 2.0 and OIDC. Specific support for AzureAD/Okta for customer tenants is not explicitly published.

APIs: REST API exists — signal-detection module "populated via our REST API." GraphQL, webhook catalogue, rate limits and SDKs are undisclosed. Data standards: ICH E2B(R2) and E2B(R3); EVCTM; FDA VAERS variant character set; FDA1932 (vet); FDA CVM HL7; MedDRA; VeDDRA.

Scale claims: Ennov-wide 450+ life-sciences customers, 500,000 users (corporate, not PV-only). PV-specific user / ICSR-volume metrics not published.

Pricing Information

No public list price is published. Subscription pricing applies for cloud; a perpetual licence is implied as available for on-premises, given the vendor's statement that "you can switch between deployment options at any time." Per-user or per-tenant pricing breakdown is undisclosed. Demo available on request. No productised free trial is advertised. Reported deal sizes, minimum commitments, setup fees, and validation-support fees are not publicly disclosed.

Implementation Details

Timeline by org size not benchmarked publicly. Ennov asserts a "production-ready system in a relatively short period of time" using a "well-defined, repeatable delivery framework" and claims "98.5% of projects delivered on time and within budget."

Implementation, training and support are sold as separate professional services. Role-based hands-on training, virtual delivery, e-learning, and "Train-the-Trainer" model. Customer support sold as ongoing service with 24/7 ticket submission and business-hour live support keyed to UK and US helpdesks.

Migration: E2B import supports ingest of historical case data sent in E2B XML by another vendor — files "may be imported directly into PV-Works." Named legacy-system migration tooling is not published. A 2025 case study describes an animal-health customer of "almost 20 years" who migrated PV operations from an on-prem installation to Ennov SaaS.

Strengths & Limitations

PharmaSpotter assessment from published vendor and third-party sources. No user reviews are on file for this product.

Strengths

Users report that the configurable workflow lets non-IT staff change processes without coding — "create new or change existing business workflows without any IT technical skills." Users report responsive customer support and a tightly linked product family ("ENNOV solutions (DOC, DOSSIER, PROCESS, RIM..) are linked and connected, allowing incredible possibilities"). In PV-specific testimonials, users report a "supportive" and "respectful" partnership style (Pure Drug Safety).

Limitations & Open Questions

Users report that as a 100% web-based product, Ennov is occasionally affected by latency and connection issues. One CTMS reviewer reported Ennov Clinical (separate product) was the worst eCRF they had used — a signal of potential UX variation by module. PV-specific reviews are too few to draw strong conclusions; published PV-Works reviews are sparse. No published GAMP 5 categorisation; no SOC 2 Type II report; no pre-validated multi-tenant SaaS claim.

Help the community

Share your experience with Ennov Pharmacovigilance Suite (PV-Works) anonymously. Your insights help pharmaceutical professionals make better software decisions.

Contribute Anonymous Feedback
Notable Customers

Publicly disclosed pharmaceutical and biotech organizations

Pure Drug SafetyBoehringer IngelheimKenvueViatrisPharmacosmosHTL Biotechnology
Vendor Information
Ennov logo

Ennov

Visit Website
Paris, Île-de-France, France
Founded 1999 (27 years)
201-500 employees
Private
View Vendor Profile
On This Page

Jump to section

Features & CapabilitiesRegulatory ComplianceTechnical SpecificationsPricing InformationImplementation DetailsNotable Customers
FDA-Compliant Solutions
Community Contributed
No Sponsored Rankings
Updated Weekly

PharmaSpotter

Comprehensive directory of pharmaceutical software solutions. QMS, LIMS, MES, analytics, and compliance tools for FDA-regulated manufacturing environments.

22 Solution Categories•Curated Data

Software Categories

  • Quality Management Systems
  • Manufacturing Execution Systems
  • Lab Information Management
  • Electronic Batch Records
  • CAPA & Deviation Management
  • Change Control
  • View All Categories →

Resources

  • RFP Template
  • Vendor Scorecard
  • Compliance Guide
  • Implementation Timeline
  • Contribute Data
© 2025 PharmaSpotter. All rights reserved.
Curated pharmaceutical software directory for FDA-regulated manufacturing environments
AboutContactContribute•Privacy PolicyTermsDisclaimer